Skip to main content

Table 2 Echocardiographic and electrocardiographic parameters

From: Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice

Phenotypic variables N-mock N-CD36 O-mock O-CD36
Heart rate (bpm) 488.75 ± 31.01 495.25 ± 14.35 443.75 ± 52.31 446.25 ± 36.69
LVEDd (mm) 3.89 ± 0.12 3.91 ± 0.18 4.07 ± 0.12*a 3.86 ± 0.09b
LVESd (mm) 2.43 ± 0.19 2.40 ± 0.22 2.63 ± 0.12*a 2.48 ± 0.07
LVPWd (mm) 0.67 ± 0.03 0.67 ± 0.06 0.70 ± 0.04 0.68 ± 0.02
LVPWs (mm) 1.08 ± 0.05 1.08 ± 0.05 1.13 ± 0.05 1.13 ± 0.05
Ejection fraction (%) 74.75 ± 3.54 75.38 ± 1.60 70.25 ± 1.58*a 72.88 ± 2.36b
Fractional shortening (%) 37.75 ± 2.76 38.00 ± 1.07 34.25 ± 0.89*a 36.38 ± 1.30b
QRS-complex width (ms) 10.30 ± 0.67 9.60 ± 0.70 10.17 ± 0.72 9.75 ± 0.62
  1. Values are mean ± SD, N = 8-12 for each group
  2. LVEDd left ventricular end-diastolic diameter, LVESd left ventricular end-systolic diameter, LVPWd left ventricular posterior wall thickness at end-diastole, LVPWs left ventricular posterior wall thickness at end-systole
  3. a P < 0.05 vs. N-CD36
  4. b P < 0.05 vs. O-mock
  5. * P < 0.05 vs. N-mock